JP Stock MarketDetailed Quotes

4503 Astellas Pharma

Watchlist
  • 1488.5
  • -5.5-0.37%
20min DelayNot Open Feb 14 15:30 JST
2.69TMarket Cap157.18P/E (Static)

Astellas Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
Total revenue
22.63%517.41B
26.17%473.12B
5.60%1.6T
17.04%414.6B
4.91%421.93B
3.09%392.15B
-1.78%374.99B
17.16%1.52T
16.58%354.25B
18.07%402.18B
Cost of revenue
29.81%98.52B
32.18%91.14B
1.43%292.49B
17.58%73.23B
1.98%75.9B
18.52%74.41B
-22.42%68.95B
13.97%288.35B
5.71%62.28B
7.30%74.42B
Gross profit
21.05%418.89B
24.82%381.99B
6.58%1.31T
16.92%341.37B
5.58%346.04B
0.04%317.74B
4.48%306.04B
17.94%1.23T
19.19%291.97B
20.82%327.76B
Operating expense
62.94%533.09B
28.04%334.17B
17.61%1.29T
13.86%387.27B
23.00%327.17B
38.16%320.95B
0.27%260.99B
20.45%1.1T
32.24%340.12B
22.06%266B
Selling and administrative expenses
12.94%225.31B
23.01%206.88B
17.43%740.11B
21.25%193.15B
22.38%199.5B
15.99%179.28B
9.64%168.18B
14.84%630.27B
11.85%159.3B
19.94%163.02B
-General and administrative expense
12.94%225.31B
23.01%206.88B
17.43%740.11B
21.25%193.15B
22.38%199.5B
15.99%179.28B
9.64%168.18B
14.84%630.27B
11.85%159.3B
19.94%163.02B
Research and development costs
6.33%79.09B
34.41%86.82B
6.54%294.19B
11.10%77.85B
11.23%74.39B
18.70%77.36B
-12.72%64.59B
12.24%276.13B
2.51%70.08B
14.14%66.88B
Depreciation and amortization
7.80%34.97B
285.88%34.99B
157.10%98.82B
252.48%32.65B
252.34%32.44B
167.43%24.67B
-15.61%9.07B
35.90%38.44B
15.26%9.26B
17.02%9.21B
-Depreciation
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-Amortization
7.80%34.97B
285.88%34.99B
157.10%98.82B
252.48%32.65B
252.34%32.44B
167.43%24.67B
-15.61%9.07B
35.90%38.44B
15.26%9.26B
17.02%9.21B
Other operating expenses
727.25%193.67B
-54.99%10.38B
6.54%167.81B
-18.29%83.84B
-16.34%23.41B
1,106.04%42.94B
-40.00%23.06B
51.00%157.52B
107.59%102.61B
50.26%27.98B
Total other operating income
-102.18%-56M
25.16%4.9B
138.63%8.69B
-80.44%220M
136.65%2.57B
1,454.98%3.28B
-75.97%3.92B
-76.13%3.64B
-89.82%1.13B
-64.64%1.09B
Operating profit
-705.28%-114.21B
6.13%47.82B
-85.60%18.95B
4.67%-45.9B
-69.45%18.87B
-103.77%-3.22B
38.09%45.06B
0.45%131.56B
-293.17%-48.14B
15.77%61.76B
Net non-operating interest income (expenses)
-31.33%-2.17B
-115.34%-162M
17.79%-550M
-116.67%-62M
-1.23%-1.65B
-94.90%105M
171.89%1.06B
-155.75%-669M
-88.26%372M
-84.18%-1.63B
Non-operating interest income
74.58%2.06B
14.75%4.33B
41.25%11.46B
68.74%4.12B
0.60%1.18B
-33.41%2.37B
307.34%3.78B
31.89%8.11B
-36.40%2.44B
181.29%1.17B
Non-operating interest expense
49.36%4.23B
65.26%4.5B
36.75%12.01B
102.03%4.19B
0.96%2.83B
50.46%2.27B
13.52%2.72B
77.39%8.78B
206.96%2.07B
115.28%2.8B
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
-827.80%-2.07B
181.20%1.93B
-351.19%-3.17B
-2,336.04%-2.7B
45.21%-223M
-164.59%-923M
96.00%686M
157.67%1.26B
92.81%-111M
-123.61%-407M
Special income (charges)
-73.58%84M
1,583.33%909M
4,491.98%9.74B
0
783.33%318M
468,100.00%9.36B
-68.24%54M
-99.13%212M
-96.15%4M
-99.85%36M
Less:Other special charges
73.58%-84M
-1,583.33%-909M
-4,491.98%-9.74B
--0
-783.33%-318M
-468,100.00%-9.36B
68.24%-54M
99.13%-212M
96.15%-4M
99.85%-36M
Other non-operating income (expenses)
Income before tax
-783.64%-118.36B
7.78%50.5B
-81.14%24.97B
-1.64%-48.66B
-71.03%17.31B
-94.00%5.33B
47.89%46.85B
-15.63%132.36B
-355.28%-47.88B
-23.70%59.76B
Income tax
-839.25%-20.7B
-6.04%12.89B
-76.45%7.92B
-778.08%-15.38B
-75.34%2.8B
-60.49%6.79B
99.81%13.72B
2.58%33.65B
16.89%-1.75B
-34.87%11.35B
Net income
-772.91%-97.66B
13.50%37.6B
-82.73%17.05B
27.85%-33.28B
-70.02%14.51B
-102.04%-1.46B
33.52%33.13B
-20.45%98.71B
-448.52%-46.13B
-20.50%48.41B
Net income continuous operations
-772.91%-97.66B
13.50%37.6B
-82.73%17.05B
27.85%-33.28B
-70.02%14.51B
-102.04%-1.46B
33.52%33.13B
-20.45%98.71B
-448.58%-46.13B
-20.50%48.41B
Noncontrolling interests
Net income attributable to the company
-772.91%-97.66B
13.50%37.6B
-82.73%17.05B
27.85%-33.28B
-70.02%14.51B
-102.04%-1.46B
33.52%33.13B
-20.45%98.71B
-448.52%-46.13B
-20.50%48.41B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-772.91%-97.66B
13.50%37.6B
-82.73%17.05B
27.85%-33.28B
-70.02%14.51B
-102.04%-1.46B
33.52%33.13B
-20.45%98.71B
-448.52%-46.13B
-20.50%48.41B
Gross dividend payment
Basic earnings per share
-774.29%-54.55
13.76%21
-82.47%9.51
26.36%-18.55
-69.54%8.09
-102.06%-0.81
35.84%18.46
-19.14%54.24
-468.62%-25.19
-19.17%26.56
Diluted earnings per share
-776.80%-54.55
13.68%20.94
-82.49%9.47
26.71%-18.55
-69.64%8.06
-102.06%-0.81
35.54%18.42
-19.33%54.09
-471.33%-25.31
-19.15%26.55
Dividend per share
0
0
16.67%70
16.67%35
0
16.67%35
0
20.00%60
20.00%30
0
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Dec 31, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022
Total revenue 22.63%517.41B26.17%473.12B5.60%1.6T17.04%414.6B4.91%421.93B3.09%392.15B-1.78%374.99B17.16%1.52T16.58%354.25B18.07%402.18B
Cost of revenue 29.81%98.52B32.18%91.14B1.43%292.49B17.58%73.23B1.98%75.9B18.52%74.41B-22.42%68.95B13.97%288.35B5.71%62.28B7.30%74.42B
Gross profit 21.05%418.89B24.82%381.99B6.58%1.31T16.92%341.37B5.58%346.04B0.04%317.74B4.48%306.04B17.94%1.23T19.19%291.97B20.82%327.76B
Operating expense 62.94%533.09B28.04%334.17B17.61%1.29T13.86%387.27B23.00%327.17B38.16%320.95B0.27%260.99B20.45%1.1T32.24%340.12B22.06%266B
Selling and administrative expenses 12.94%225.31B23.01%206.88B17.43%740.11B21.25%193.15B22.38%199.5B15.99%179.28B9.64%168.18B14.84%630.27B11.85%159.3B19.94%163.02B
-General and administrative expense 12.94%225.31B23.01%206.88B17.43%740.11B21.25%193.15B22.38%199.5B15.99%179.28B9.64%168.18B14.84%630.27B11.85%159.3B19.94%163.02B
Research and development costs 6.33%79.09B34.41%86.82B6.54%294.19B11.10%77.85B11.23%74.39B18.70%77.36B-12.72%64.59B12.24%276.13B2.51%70.08B14.14%66.88B
Depreciation and amortization 7.80%34.97B285.88%34.99B157.10%98.82B252.48%32.65B252.34%32.44B167.43%24.67B-15.61%9.07B35.90%38.44B15.26%9.26B17.02%9.21B
-Depreciation --0--0--0--0--0--0--0--0--0--0
-Amortization 7.80%34.97B285.88%34.99B157.10%98.82B252.48%32.65B252.34%32.44B167.43%24.67B-15.61%9.07B35.90%38.44B15.26%9.26B17.02%9.21B
Other operating expenses 727.25%193.67B-54.99%10.38B6.54%167.81B-18.29%83.84B-16.34%23.41B1,106.04%42.94B-40.00%23.06B51.00%157.52B107.59%102.61B50.26%27.98B
Total other operating income -102.18%-56M25.16%4.9B138.63%8.69B-80.44%220M136.65%2.57B1,454.98%3.28B-75.97%3.92B-76.13%3.64B-89.82%1.13B-64.64%1.09B
Operating profit -705.28%-114.21B6.13%47.82B-85.60%18.95B4.67%-45.9B-69.45%18.87B-103.77%-3.22B38.09%45.06B0.45%131.56B-293.17%-48.14B15.77%61.76B
Net non-operating interest income (expenses) -31.33%-2.17B-115.34%-162M17.79%-550M-116.67%-62M-1.23%-1.65B-94.90%105M171.89%1.06B-155.75%-669M-88.26%372M-84.18%-1.63B
Non-operating interest income 74.58%2.06B14.75%4.33B41.25%11.46B68.74%4.12B0.60%1.18B-33.41%2.37B307.34%3.78B31.89%8.11B-36.40%2.44B181.29%1.17B
Non-operating interest expense 49.36%4.23B65.26%4.5B36.75%12.01B102.03%4.19B0.96%2.83B50.46%2.27B13.52%2.72B77.39%8.78B206.96%2.07B115.28%2.8B
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests -827.80%-2.07B181.20%1.93B-351.19%-3.17B-2,336.04%-2.7B45.21%-223M-164.59%-923M96.00%686M157.67%1.26B92.81%-111M-123.61%-407M
Special income (charges) -73.58%84M1,583.33%909M4,491.98%9.74B0783.33%318M468,100.00%9.36B-68.24%54M-99.13%212M-96.15%4M-99.85%36M
Less:Other special charges 73.58%-84M-1,583.33%-909M-4,491.98%-9.74B--0-783.33%-318M-468,100.00%-9.36B68.24%-54M99.13%-212M96.15%-4M99.85%-36M
Other non-operating income (expenses)
Income before tax -783.64%-118.36B7.78%50.5B-81.14%24.97B-1.64%-48.66B-71.03%17.31B-94.00%5.33B47.89%46.85B-15.63%132.36B-355.28%-47.88B-23.70%59.76B
Income tax -839.25%-20.7B-6.04%12.89B-76.45%7.92B-778.08%-15.38B-75.34%2.8B-60.49%6.79B99.81%13.72B2.58%33.65B16.89%-1.75B-34.87%11.35B
Net income -772.91%-97.66B13.50%37.6B-82.73%17.05B27.85%-33.28B-70.02%14.51B-102.04%-1.46B33.52%33.13B-20.45%98.71B-448.52%-46.13B-20.50%48.41B
Net income continuous operations -772.91%-97.66B13.50%37.6B-82.73%17.05B27.85%-33.28B-70.02%14.51B-102.04%-1.46B33.52%33.13B-20.45%98.71B-448.58%-46.13B-20.50%48.41B
Noncontrolling interests
Net income attributable to the company -772.91%-97.66B13.50%37.6B-82.73%17.05B27.85%-33.28B-70.02%14.51B-102.04%-1.46B33.52%33.13B-20.45%98.71B-448.52%-46.13B-20.50%48.41B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders -772.91%-97.66B13.50%37.6B-82.73%17.05B27.85%-33.28B-70.02%14.51B-102.04%-1.46B33.52%33.13B-20.45%98.71B-448.52%-46.13B-20.50%48.41B
Gross dividend payment
Basic earnings per share -774.29%-54.5513.76%21-82.47%9.5126.36%-18.55-69.54%8.09-102.06%-0.8135.84%18.46-19.14%54.24-468.62%-25.19-19.17%26.56
Diluted earnings per share -776.80%-54.5513.68%20.94-82.49%9.4726.71%-18.55-69.64%8.06-102.06%-0.8135.54%18.42-19.33%54.09-471.33%-25.31-19.15%26.55
Dividend per share 0016.67%7016.67%35016.67%35020.00%6020.00%300
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Trending Stocks

Heat List Heat List
No. Symbol Price
Toyota Motor
7203
2804.5
ASICS
7936
3518.0
Sony Group
6758
3705.0
4
Harmonic Drive Systems
6324
4350
5
SoftBank Group
9984
9637.0
Log In for the Full List
Unlock Now
Headlines
Unanimously opposed! The OpenAI Board of Directors officially rejected Musk's acquisition proposal.
Feb 15 15:10
Weekend reading | The successive rise of PDD Holdings, Xiaohongshu, POP MART, and Pang Donglai all share a common underlying logic.
Feb 15 14:24
Hillhouse HHLR Advisors continues to focus on China Assets: The top ten heavily weighted Chinese concept stocks in Q4 occupy 8 positions!
Feb 15 10:22
DeepSeek has sparked an unprecedented wave of AI applications! The market increasingly believes in the 'bull market narrative' of Software stocks.
Feb 14 23:34
Futu Morning Report | Trump signs a significant "reciprocal tariff", which may take effect on April 2! Bridgewater reduced its shareholding in Apple and NVIDIA in the fourth quarter and established a new position in Tesla.
Feb 14 08:31